← USPTO Patent Applications

Compositions and Methods for Assessing Kinase Activity

Application US20260077065A1 Kind: A1 Mar 19, 2026

Inventors

Yichi Su, Michael Z. Lin, Yan Wu

Abstract

Provided are nucleic acids encoding kinase-modulated bioluminescent indicator (KiMBI) polypeptides. In certain embodiments, a nuclei acid of the present disclosure encodes a KiMBI polypeptide comprising a first bioluminescent enzyme fragment, a phospho-binding domain, a 5 second bioluminescent enzyme fragment capable of forming an active bioluminescent enzyme with the first fragment via enzyme fragment complementation, and a kinase substrate bound by the phospho-binding domain when phosphorylated. KiMBI polypeptide may be fused to one or more fluorescent proteins, e.g., which exhibit resonance energy transfer (RET). Also provided are KiMBI polypeptides encoded by the nucleic acids of the present disclosure. Cells that express 10 a KiMBI polypeptide are also provided, as are non-human animals comprising such cells. Also provided are methods of assessing activity of a kinase of interest in a non-huma animal, and methods of assessing a test agent for the ability to inhibit a kinase of interest in a non-human animal.

CPC Classifications

A61K 49/0008 A61K 49/0021 A61K 49/0045 C12N 9/12 C12N 15/86 C12Y 207/11001 C12N 2740/15043 C12N 2750/14143

Filing Date

2023-09-15

Application No.

19110335